» Articles » PMID: 35163824

Identification of Corosolic and Oleanolic Acids As Molecules Antagonizing the Human RORγT Nuclear Receptor Using the Calculated Fingerprints of the Molecular Similarity

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Feb 15
PMID 35163824
Authors
Affiliations
Soon will be listed here.
Abstract

RORγT is a protein product of the RORC gene belonging to the nuclear receptor subfamily of retinoic-acid-receptor-related orphan receptors (RORs). RORγT is preferentially expressed in Th17 lymphocytes and drives their differentiation from naive CD4+ cells and is involved in the regulation of the expression of numerous Th17-specific cytokines, such as IL-17. Because Th17 cells are implicated in the pathology of autoimmune diseases (e.g., psoriasis, inflammatory bowel disease, multiple sclerosis), RORγT, whose activity is regulated by ligands, has been recognized as a drug target in potential therapies against these diseases. The identification of such ligands is time-consuming and usually requires the screening of chemical libraries. Herein, using a Tanimoto similarity search, we found corosolic acid and other pentacyclic tritepenes in the library we previously screened as compounds highly similar to the RORγT inverse agonist ursolic acid. Furthermore, using gene reporter assays and Th17 lymphocytes, we distinguished compounds that exert stronger biological effects (ursolic, corosolic, and oleanolic acid) from those that are ineffective (asiatic and maslinic acids), providing evidence that such combinatorial methodology (in silico and experimental) might help wet screenings to achieve more accurate results, eliminating false negatives.

Citing Articles

Synergistic Effect of Mixtures and Leaf Extract in Reducing Obesity in High-Fat Diet-Fed Mice.

Lee K, Kim H, Kim J, Shim J, Lee J Biology (Basel). 2025; 13(12.

PMID: 39765714 PMC: 11673097. DOI: 10.3390/biology13121047.


Overview of Ursolic Acid Potential for the Treatment of Metabolic Disorders, Autoimmune Diseases, and Cancers via Nuclear Receptor Pathways.

Kadasah S, Radwan M Biomedicines. 2023; 11(10).

PMID: 37893218 PMC: 10604592. DOI: 10.3390/biomedicines11102845.


Harnessing Oleanolic Acid and Its Derivatives as Modulators of Metabolic Nuclear Receptors.

Radwan M, Kadasah S, Aljubiri S, Alrefaei A, El-Maghrabey M, El Hamd M Biomolecules. 2023; 13(10).

PMID: 37892147 PMC: 10604226. DOI: 10.3390/biom13101465.


In Vitro and In Vivo Anti-Psoriasis Activity of Fruit Extracts via JAK-STAT Modulation.

Lee J, Lee M Life (Basel). 2023; 13(8).

PMID: 37629529 PMC: 10455168. DOI: 10.3390/life13081671.


Corosolic Acid Inhibits Secretory Phospholipase AIIa as an Anti-Inflammatory Function and Exhibits Anti-Tumor Activity in Ehrlich Ascites Carcinoma Bearing Mice.

Pundalik S, Hanumappa K, Giresha A, Urs D, Rajashekarappa S, Muniyappa N J Inflamm Res. 2023; 15:6905-6921.

PMID: 36619941 PMC: 9811966. DOI: 10.2147/JIR.S383441.


References
1.
Liu J . Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol. 1995; 49(2):57-68. DOI: 10.1016/0378-8741(95)90032-2. View

2.
Solt L, Kumar N, He Y, Kamenecka T, Griffin P, Burris T . Identification of a selective RORγ ligand that suppresses T(H)17 cells and stimulates T regulatory cells. ACS Chem Biol. 2012; 7(9):1515-9. PMC: 3448878. DOI: 10.1021/cb3002649. View

3.
Marks B, Craft J . Barrier immunity and IL-17. Semin Immunol. 2009; 21(3):164-71. PMC: 2692766. DOI: 10.1016/j.smim.2009.03.001. View

4.
Dal Pra M, Carta D, Szabadkai G, Suman M, Frion-Herrera Y, Paccagnella N . Targeting RORs nuclear receptors by novel synthetic steroidal inverse agonists for autoimmune disorders. Bioorg Med Chem. 2018; 26(8):1686-1704. DOI: 10.1016/j.bmc.2018.02.018. View

5.
Lin L, Ibrahim A, Xu X, Farber J, Avanesian V, Baquir B . Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog. 2009; 5(12):e1000703. PMC: 2792038. DOI: 10.1371/journal.ppat.1000703. View